Lee Silsby Compounding Pharmacy, the leader in custom compounded medications for autism, announces its newest product, Enhansa, Enhanced Absorption Curcumin Supplement. Curcumin is the principal curcuminoid found in the popular Indian spice turmeric. Enhansa was created by Lee Silsby Compounding Pharmacy. To date, several hundred patients on the spectrum are using Enhansa. Current product order rates indicate a high level of both patient and physician satisfaction.
Enhansa is clinically proven to increase intracellular Glutathione, reduce levels of nearly every elevated inflammatory cytokine found in autistic patients and improve liver detoxification. In addition, Enhansa acts as an anti-viral and anti-fungal agent and is a potent PPAR Gamma Agonist and NF-Kapp B inhibitor. Patient benefits include improved digestion, detoxification and antioxidant support.
Unlike other commercial curcumin products, Enhansa is free of all heavy metals and is clinically proven to have seven to eight times the absorption rate over standard curcumin extracts. Enhansa is available in 150 mg capsules, 600 mg capsules and powder form. Enhansa is available as an over the counter supplement, and can also be written as a prescription. Some insurances are covering Enhansa.
Lee Silsby Compounding Pharmacy is located in Cleveland, Ohio and includes a FDA approved nutritional supplement production facility, Class 100 certified clean room for preparing sterile products, and state-of-the-art compounding facilities. The pharmacists are available to consult with doctors and healthcare professionals around the globe. They ship internationally and accept several health insurance plans including TriCare military insurance.
The "Treatment" category is sponsored by Lee Silsby, the leader in quality compounded medications for autism.